AbbVie gains on updated 2018 EPS guidance

AbbVie Inc. (NYSE:ABBV) gained $14.91 (14%) to $123.21 on Friday after increasing its full-year 2018 non-GAAP EPS guidance to $7.33-$7.43 from $6.37-$6.57. The pharma said the adjusted range reflects "the

Read the full 305 word article

User Sign In